Supplemental Information

ARTICLE Supplemental Information <ul style="display: flex;"><li style="flex:1">PEDIATRICS Volume 146, Number 3, September 2020 </li><li style="flex:1">1</li></ul>SUPPLEMANTAL FIGURE 3 Example individualized antibiotic prescribing feedback report used in the DART study. Amox, amoxicillin; Clav, clavulanate; Rx, prescription. 2ARTICLE SUPPLEMANTAL FIGURE 4 aRR for antibiotic prescribing from ITT analyses of the DART primary and secondary outcomes by study phase. <ul style="display: flex;"><li style="flex:1">PEDIATRICS Volume 146, Number 3, September 2020 </li><li style="flex:1">3</li></ul>SUPPLEMANTAL TABLE 5 ICD-10 Codes Used To Define ARTI Visits Diagnosis AOM <ul style="display: flex;"><li style="flex:1">Included Conditions </li><li style="flex:1">ICD-10 Codesa </li></ul><ul style="display: flex;"><li style="flex:1">Acute serous, allergic, and </li><li style="flex:1">H65.0n, H65.11n, H65.19n, H65.2n, </li></ul>H65.3n, H65.41n, H65.49n, H65.9n, H66.00n, H66.01n, H66.1n, H66.2n, H66.3Xn, H66.4n, H66.9n, and/or H67.n nonsuppurative otitis media; chronic serous, mucoid, allergic, and nonsuppurative otitis media Pharyngitis Sinusitis <ul style="display: flex;"><li style="flex:1">Acute pharyngitis and tonsillitis </li><li style="flex:1">J02, J02.n, J03, J03.00, J03.8n, and/or </li></ul>J03.9n J01.0n, J01.1n, J01.2n, J01.3n, J01.4n, J01.8n, and/or J01.9n J00, J06.n, J10.1, J11.1, J20.3-J20.9, J21.n, and/or J40 Acute maxillary, frontal, ethmoidal, sphenoidal, and pansinusitis Common cold, upper respiratory tract infection, influenza, bronchitis, and bronchiolitis Viral ARTIsb Additional bacterial Central venous catheter infections, infection after immunization, bites and scratches, infections due to specific pathogens (eg, Salmonella), sexually transmitted diseases, neutropenia, cellulitis, abscess, otitis externa, chronic otitis media, pneumonia, chronic sinusitis, impetigo, lymphangitis, lymphadenitis, acne and other skin conditions, septic arthritis, osteomyelitis and discitis, myositis, pyelonephritis, cystitis, urinary tract infection, salpingitis, peritonitis, pelvic infections, sepsis, and bacteremia T80.2n, T88.0n, W50.3n, W53.n1Xn, W54.0XXn, W55.n1Xn, W56.n1Xn, W58.n1Xn, W59.n1Xn, W61.n1xn, Y04.1xxn, A01.0n, A01.n, A02.n, A03.n, A04.n, A18.0n, A22.7, A23.n, A26-27.n, A28.0, A28.2-9, A32.n, A33, A37.n, A38.1-9, A40-41.n, A42.7, A48-59.n, A63.8, A64, A69.2n, A74.8-9n, B37.7, B78.1, B95.n, B96.n, D70.n, H00.036, H05.01n, H60.0-3n, H62.4n, H66.1-3n, I00, I01.n, J13-8.n, J20.0-2, J32.n, J36, J39.0-1, K04.0, K04.4, K04.6-7, K12.2, K61.n, L01-8.n except L03.213 and L08.1, L70.n, L73.0, L88, L92.8, L98.0, L98.3, M00-1.n, M46.2-3n, M60.0n, M86.n, N11.0-1, 13N.6, N15.1, N15.9, N16, N30.n, N34.0-2, N39.0, N70.n, N71-7.n, N98.0, P36-9.n, R65.n, and/ or R78.81 infectionsc a An “n” within or at the end of a code (eg, H65.0n) denotes that any ICD-10 code with any numeral or letter in that position is included. bExcludes codes in which bacterial pathogens are noted (eg, Mycoplasma). These were used to exclude visits from being categorized as viral in the analysis. cSUPPLEMANTAL TABLE 6 ARTI Visits and Unadjusted Antibiotic Prescribing Rates by Study Time Period <ul style="display: flex;"><li style="flex:1">Characteristic </li><li style="flex:1">Baseline Module 1 Module 2 Module 3 Postintervention </li><li style="flex:1">Total </li></ul>No. all ARTI Received antibiotics, n (%) No. all pharyngitis Received antibiotics, n (%) 42 191 17 183 (40.7) 12 206 5394 6287 2515 (40.0) 2130 987 7319 2594 (35.4) 2023 785 8166 3022 (37.0) 1765 691 8760 3444 (39.3) 72 723 28 758 (39.5) 20 464 8881 (43.4) 34 324 1942 2340 1024 (43.8) (44.2) 19 442 (46.3) 2760 (38.8) 3633 (39.2) <ul style="display: flex;"><li style="flex:1">4265 </li><li style="flex:1">No. viral ARTI </li><li style="flex:1">4224 </li></ul><ul style="display: flex;"><li style="flex:1">224 (5.3) </li><li style="flex:1">Received antibiotics, n 1234 (6.3) 143 (5.2) 146 (4.0) 195 (4.6) </li></ul><ul style="display: flex;"><li style="flex:1">(%) </li><li style="flex:1">(5.7) </li></ul>No. streptococcal pharyngitis <ul style="display: flex;"><li style="flex:1">4307 </li><li style="flex:1">774 </li><li style="flex:1">618 </li><li style="flex:1">567 </li><li style="flex:1">840 </li><li style="flex:1">7106 </li></ul>Received second-line antibiotics, n (%) No. AOM Received second-line antibiotics, n (%) No. sinusitis <ul style="display: flex;"><li style="flex:1">566 (13.1) 61 (7.9) 66 (10.7) 38 (6.7) </li><li style="flex:1">60 (7.1) </li><li style="flex:1">791 </li></ul>(11.1) 12 812 3411 (26.6) 5123 7470 2055 (27.5) 3103 997 264 (26.5) 370 1131 252 (22.3) 532 1530 427 (27.9) 606 1684 413 (24.5) 512 Received second-line antibiotics, n (%) <ul style="display: flex;"><li style="flex:1">575 (18.5) 55 (14.9) 54 (10.2) 75 (12.4) </li><li style="flex:1">61 (11.9) </li><li style="flex:1">820 </li></ul>(16.0) 4

Supplemental Information

Details

Download

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

Support